FDA Inspection 991448 — Nomax, Inc.

Nomax, Inc. — FEI 1937310

The FDA completed an inspection of Nomax, Inc. on Oct 27, 2016 in Saint Louis, MO. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 7 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Oct 27, 2016
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Saint Louis, MO (United States)

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
312721 CFR 820.80(e)Documentation
312821 CFR 820.90(a)Nonconforming product control
317221 CFR 820.198(c)Investigation of device failures
342521 CFR 820.50(a)(1)Evaluation and Selection, Suppliers, Contractors, etc.
366821 CFR 820.20(c)Management review dates
369621 CFR 820.100(b)Documentation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.